New cell therapy, Cilta-cel, shows promise in the treatment of multiple myeloma, providing a personalised approach with the ...

Glox Therapeutics secures £500K from a £3M fund to develop antibiotics targeting antimicrobial-resistant lung infections in ...

Rigel Pharmaceuticals has enrolled the first patient in a Phase I trial to evaluate fostamatinib as a treatment for sickle ...

Cancer Research UK, Cytovation, and the Norwegian Cancer Society collaborate to advance treatment for adrenocortical ...

Learn about the gut-brain connection in mental health and how targeting serotonin in the gut could revolutionise ...

New study reveals that TLE6 protein deficiency causes male infertility in mice. These findings suggest potential genetic ...

Grifols has received a $21 million grant from The Michael J. Fox Foundation to fund a pioneering study aimed at identifying ...

Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.

UVA researchers found that continuous glucose monitor data can predict nerve, eye, and kidney damage from type 1 diabetes.

Enhance compliance and quality in the health and wellness market with Eurofins' GMP certification programme for dietary and ...

Researchers at UVA have developed computer models to create targeted antibiotics, aiming to combat antibiotic resistance.